Filter Content:

News

8 Dec 2022

Are Leukaemia-Linked Immune Cells Key Drivers of Autoimmune Disease?

New research has indicated that gene variants associated with leukaemia, can produce ‘rogue’ immune cells that drive autoimmune diseases…

General Healthcare

11 Oct 2022

Spencer Gore named among UK’s Top 50 Most Ambitious Business Leaders for 2022

Spencer Gore, Founder of EMJ has been named as one of The LDC Top 50 Most Ambitious Business Leaders for 2022.

General Healthcare

6 Sep 2022

EMJ announces partnership with the World Telehealth Initiative

EMJ is joining forces with the World Telehealth Initiative to support their mission to provide sustainable medical expertise through volunteer physicians…

Microbiology & Infectious Diseases

24 Aug 2022

Protective Effects of BCG Vaccine In COVID-19

In novel results published from a double-blind, placebo-controlled study of patients with Type 1 diabetes, researchers demonstrated a protective effect of Bacillus Calmette–Guerin (BCG) vaccine.

4 Aug 2022

Laying the Foundation Towards Long-Term Survival in Patients with High-Risk Acute Myeloid Leukaemia

For many patients diagnosed with acute myeloid leukaemia (AML), long-term survival remains elusive….

Gastroenterology

8 Jul 2022

Predicting Type 2 Diabetes Remission in Patients of Gastric Bypass

Blood ceramide levels could help predict whether patients with Type 2 diabetes who undergo gastric bypass surgery will experience remission…

EMJ

General Healthcare

5 Jul 2022

EMJ ranked as one of Britain's fastest-growing private companies

EMJ, Europe’s leading digital health communications company, has been ranked in the 2022 edition of The Sunday Times 100.

1 Jul 2022

Prevalence of Atopic Dermatitis in People of Colour

The results of a new literature review indicate that AD prevalence is higher in individuals identifying as Black or African American…

Loading posts...

« Previous 1 … 395 396 397 398 399 … 764 Next »